Table 1. C-9 protects HGEC viability from Stx2 toxic effect but not from SubAB.
C-9 (µM) | Viability(%) |
Cytotoxicity protection (%) | ||
---|---|---|---|---|
C-9, 48 h | C-9 48 h, SubAB 24 h | C-9 48 h, Stx2 24 h | ||
0 | 94.0 ± 1.2 | 77.2 ± 4.5 | 54.0 ± 1.5 | 0 |
0.05 | 80.1 ± 7.3 | 75.0 ± 7.2 | 72.1 ± 4.3* | 70 |
0.5 | 85.0 ± 3.6 | 75.2 ± 4.5 | 87.0 ± 10.0* | 100 |
1 | 87.5 ± 3.5 | 73.0 ± 6.3 | 87.3 ± 7.3* | 100 |
5 | 83.2 ± 8.6 | 72.0 ± 7.5 | 93.0 ± 8.5* | 100 |
P<0.05, n 4 [C-9 48h, Stx2 24h] vs Stx2